-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Adverum Biotechnologies, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2013 to Q1 2025.
- Adverum Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $2.78M, a 33.3% decline year-over-year.
- Adverum Biotechnologies, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $13M, a 24.5% decline year-over-year.
- Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $14.4M, a 18.3% decline from 2023.
- Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $17.6M, a 12.5% decline from 2022.
- Adverum Biotechnologies, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $20.1M, a 20.3% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)